Endocrinology · Type B Insulin Resistance Syndrome

Biology and Diagnosis: Finding the Root Cause

At a Glance

Type B Insulin Resistance Syndrome (TBIRS) is an autoimmune condition where antibodies attack insulin receptors, causing severe blood sugar swings. Diagnosis requires specialized blood tests for IRAb titers and low adiponectin levels to distinguish it from standard diabetes.

Understanding the biology of Type B Insulin Resistance Syndrome (TBIRS) is the first step in regaining control of your health. While standard diabetes involves the body struggling to make or use insulin efficiently, TBIRS is a case of “mistaken identity” by your immune system ^[1]^[2].

The Biology of the “Lock and Key”

To understand TBIRS, it helps to think of insulin as a key and the insulin receptor as a lock on your cells. In a healthy body, the key fits into the lock and opens the door to let sugar (glucose) in for energy.

In TBIRS, your body produces anti-insulin receptor autoantibodies (IRAbs). These are rogue proteins that act like “gum” stuck in the lock ^[2]^[3].

Blocking (Antagonist) Effect: Most often, these antibodies jam the lock so the insulin “key” cannot get in. This leaves sugar trapped in your bloodstream, leading to severe hyperglycemia ^[2]^[4].
Mimicking (Agonist) Effect: Sometimes, these same antibodies actually turn the lock themselves, even without insulin. This “tricks” the cell into taking in too much sugar all at once, leading to sudden, dangerous hypoglycemia (low blood sugar) ^[5]^[6].

TBIRS vs. Other Conditions

It is common for TBIRS to be confused with other forms of severe insulin resistance. Your doctors use specific clues to tell them apart:

Type A Insulin Resistance: This is a congenital (present from birth) genetic condition caused by a mutation in the INSR gene (the blueprint for the lock) ^[7]. Unlike TBIRS, Type A is not autoimmune and does not involve antibodies ^[8].
Insulin Autoimmune Syndrome (Hirata Disease): In this condition, the antibodies attack the insulin itself (the key) rather than the receptor (the lock). Doctors differentiate this by looking at your insulin-to-C-peptide ratio ^[9]^[10].
Insulin Allergy: This is an immune reaction to the insulin injection itself, which presents differently and typically does not cause the same extreme resistance seen in TBIRS ^[10].

Your Diagnostic Completeness Checklist

A definitive diagnosis of TBIRS requires more than just a high blood sugar reading. Because it is often associated with other conditions like Systemic Lupus Erythematosus (SLE), a full workup is essential ^[11]^[12]. Ensure your diagnostic report includes the following:

Test Category	Specific Test	Why It Matters
The Smoking Gun	IRAb Titers	Confirms the presence of antibodies attacking your receptors ^[6]. Note: These tests are highly specialized and often must be sent to specific reference labs, meaning results can take weeks to return.
Metabolic Profile	Serum Insulin & C-Peptide	Shows if your body is producing massive insulin that isn’t working ^[10].
Hormone Markers	Adiponectin	Extremely low (profound) levels of adiponectin are a hallmark clinical marker for TBIRS, distinguishing it from typical Type 2 diabetes and obesity ^[13]^[14].
Autoimmune Panel	ANA & Anti-dsDNA	Screens for underlying lupus or other rheumatologic diseases ^[12].
Genetic Screening	INSR Gene Sequencing	Used to rule out Type A (genetic) insulin resistance if suspected ^[8].

By confirming these markers, your care team can move from treating symptoms to targeting the actual cause: the overactive immune system ^[15]^[16].

Common questions in this guide

How is Type B Insulin Resistance Syndrome diagnosed?

Doctors diagnose TBIRS by sending your blood to a specialized lab to check for anti-insulin receptor autoantibodies (IRAbs). They will also measure your insulin, C-peptide, and adiponectin levels to confirm the diagnosis and rule out other forms of diabetes.

What is the difference between Type A and Type B insulin resistance?

Type A is a genetic condition present from birth that is caused by a mutation in the INSR gene. Type B is an autoimmune condition that usually develops later in life when the body mistakenly creates antibodies that attack its own insulin receptors.

Why do I need an autoimmune panel for TBIRS?

TBIRS is frequently associated with other autoimmune diseases, particularly Systemic Lupus Erythematosus (lupus). An autoimmune panel, including ANA and anti-dsDNA tests, helps doctors identify these underlying conditions so they can be properly treated.

What does a low adiponectin level mean in TBIRS?

Profoundly low adiponectin levels are a hallmark marker of TBIRS. Checking these levels helps your care team easily distinguish TBIRS from standard Type 2 diabetes or obesity-related insulin resistance.

Can TBIRS cause both high and low blood sugar?

Yes. The autoantibodies in TBIRS typically block insulin from working, leading to severe high blood sugar. However, they can sometimes mimic insulin and force sugar into cells rapidly, causing sudden and dangerous low blood sugar (hypoglycemia).

Curated prompts to bring to your next appointment.

1.Have my insulin receptor autoantibody (IRAb) titers been specifically tested to confirm this is Type B and not Type A?
2.How do my C-peptide levels compare to my insulin levels, and what does that tell us about my diagnosis?
3.Have we performed a full autoimmune panel, including ANA and anti-dsDNA, to check for conditions like lupus?
4.Should we consider genetic testing for the INSR gene to definitively rule out a congenital cause?
5.Are my adiponectin levels profoundly low, as is typical in TBIRS?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References (16)

1
Rituximab for the treatment of type B insulin resistance syndrome: a case report and review of the literature.
Iseri K, Iyoda M, Shikida Y, et al.
Diabetic medicine : a journal of the British Diabetic Association 2017; (34(12)):1788-1791 doi:10.1111/dme.13524.
PMID: 29044634
2
Insulin autoimmune syndrome: from diagnosis to clinical management.
Censi S, Mian C, Betterle C
Annals of translational medicine 2018; (6(17)):335 doi:10.21037/atm.2018.07.32.
PMID: 30306074
3
[Type B insulin resistance syndrome].
Sjöholm Å, João Pereira M, Nilsson T, et al.
Lakartidningen 2020; (117()).
PMID: 32969484
4
Practical Clinical Applications of Islet Autoantibody Testing in Type 1 Diabetes.
Winter WE, Pittman DL, Jialal I
The journal of applied laboratory medicine 2022; (7(1)):197-205 doi:10.1093/jalm/jfab113.
PMID: 34996067
5
Systematic Review-Type B Insulin Resistance With Isolated Hypoglycemia and Suppressed Insulin.
Brown N, Elston MS
The Journal of clinical endocrinology and metabolism 2024; (109(4)):936-943 doi:10.1210/clinem/dgad467.
PMID: 37552775
6
Type B insulin resistance syndrome associated with connective tissue disease and psoriasis.
Łebkowska A, Krentowska A, Adamska A, et al.
Endocrinology, diabetes & metabolism case reports 2020; (2020()).
PMID: 32755965
7
Clinical characteristics of adolescent cases with Type A insulin resistance syndrome caused by heterozygous mutations in the β-subunit of the insulin receptor (INSR) gene.
Takasawa K, Tsuji-Hosokawa A, Takishima S, et al.
Journal of diabetes 2019; (11(1)):46-54 doi:10.1111/1753-0407.12797.
PMID: 29877041
8
A New Heterozygous Variant of c.1225_1227delTTC (p.Phe409del) in Insulin Receptor Gene Associated with Severe Insulin Resistance and Hyperandrogenemia in an Adolescent Female with Type A Severe Insulin Resistance Syndrome.
Song Y, Lei W, Huang Q, et al.
Diabetes, metabolic syndrome and obesity : targets and therapy 2024; (17()):4389-4396 doi:10.2147/DMSO.S481745.
PMID: 39619220
9
Hypoglycemia Caused by Exogenous Insulin Antibody Syndrome: A Large Single-Center Case Series From China.
Liu Y, Ping F, Yu J, et al.
The Journal of clinical endocrinology and metabolism 2023; (108(3)):713-717 doi:10.1210/clinem/dgac578.
PMID: 36219196
10
A pitfall in diagnosing type B insulin resistance syndrome: Suspected antibody interference in a patient with insulin allergy.
Manda S, Miya A, Nakamura A, et al.
Journal of diabetes investigation 2026; (17(3)):546-548 doi:10.1111/jdi.70235.
PMID: 41574820
11
Type B insulin resistance syndrome.
Willard DL, Stevenson M, Steenkamp D
Current opinion in endocrinology, diabetes, and obesity 2016; (23(4)):318-23 doi:10.1097/MED.0000000000000263.
PMID: 27254267
12
A case of systemic lupus erythematosus in a patient with Noonan syndrome with recurrent severe hypoglycaemia.
Masuoka S, Tanaka T, Kanaji M, et al.
Modern rheumatology case reports 2024; (8(2)):280-285 doi:10.1093/mrcr/rxae004.
PMID: 38252597
13
An Explanation for the Adiponectin Paradox.
Kalkman HO
Pharmaceuticals (Basel, Switzerland) 2021; (14(12)) doi:10.3390/ph14121266.
PMID: 34959666
14
Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction.
Achari AE, Jain SK
International journal of molecular sciences 2017; (18(6)) doi:10.3390/ijms18061321.
PMID: 28635626
15
Combined Immunosuppressive Therapy Induces Remission in Patients With Severe Type B Insulin Resistance: A Prospective Cohort Study.
Klubo-Gwiezdzinska J, Lange M, Cochran E, et al.
Diabetes care 2018; (41(11)):2353-2360 doi:10.2337/dc18-0884.
PMID: 30201849
16
Diabetic Ketoacidosis Without Diabetes.
Willard D, Upadhyay J, Kim C, Steenkamp D
The Journal of clinical endocrinology and metabolism 2016; (101(11)):3870-3873 doi:10.1210/jc.2016-2146.
PMID: 27636019

This page explains the biology and diagnosis of Type B Insulin Resistance Syndrome for educational purposes. Always consult an endocrinologist and rheumatologist for accurate testing and interpretation of your laboratory results.

Get notified when new evidence is published on Insulin-resistance syndrome type B.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents